Pharmacogenetics in the treatment of breast cancer

被引:0
|
作者
V Stearns
N E Davidson
D A Flockhart
机构
[1] Breast Cancer Program,Division of Clinical Pharmacology
[2] Sidney Kimmel Comprehensive Cancer Center,undefined
[3] Johns Hopkins School of Medicine,undefined
[4] Indiana University School of Medicine,undefined
[5] Wishard Hospital,undefined
来源
The Pharmacogenomics Journal | 2004年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:143 / 153
页数:10
相关论文
共 50 条
  • [1] Pharmacogenetics in the treatment of breast cancer
    Stearns, V
    Davidson, NE
    Flockhart, DA
    PHARMACOGENOMICS JOURNAL, 2004, 4 (03): : 143 - 153
  • [2] Pharmacogenetics and oncology treatment for breast cancer
    Marsh, Sharon
    McLeod, Howard L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 119 - 127
  • [3] The role of pharmacogenetics in selection of breast cancer treatment
    Roisin Connolly
    Vered Stearns
    Current Breast Cancer Reports, 2009, 1 (4) : 190 - 197
  • [4] The Role of Pharmacogenetics in Selection of Breast Cancer Treatment
    Connolly, Roisin
    Stearns, Vered
    CURRENT BREAST CANCER REPORTS, 2009, 1 (04) : 190 - 197
  • [5] Tamoxifen pharmacogenetics: implications for breast cancer treatment
    Brauch, H.
    Schroth, W.
    Eichelbaum, M.
    Schwab, M.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 : A67 - A67
  • [6] Pharmacokinetics and pharmacogenetics in breast cancer patients systemic treatment
    Huszno, Joanna
    Nowara, Elzbieta
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (04): : 159 - 170
  • [7] Pharmacogenetics of anti-estrogen treatment of breast cancer
    Del Re, Marzia
    Michelucci, Angela
    Simi, Paolo
    Danesi, Romano
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 442 - 450
  • [8] Pharmacogenetics in the management of breast cancer - prospects for individualised treatment
    Blackhall, Fiona H.
    Howell, Sacha
    Newman, Bill
    FAMILIAL CANCER, 2006, 5 (02) : 151 - 157
  • [9] Pharmacogenetics in the Management of Breast Cancer – Prospects for Individualised Treatment
    Fiona H. Blackhall
    Sacha Howell
    Bill Newman
    Familial Cancer, 2006, 5 : 151 - 157
  • [10] Impact of pharmacogenetics on docetaxel as neoadjuvant treatment of breast cancer.
    Xie, Hanjing
    Bergh, Jonas C. S.
    Hellstrom, Mats
    Hatschek, Thomas
    Sim, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)